V030-1299 Screening compound: 5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

V030-1299 Screening compound: 5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide
V030-1299 Screening compound: 5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-1299
5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-1299

Molecular Formula

C32H36N4O4 (C32 H36 N4 O4)

Compound Name

5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

IUPAC name

5-[2-(benzyloxy)acetamido]-1-[(3-methylphenyl)methyl]-N-[2-(morpholin-4-yl)ethyl]-1H-indole-2-carboxamide

SMILES

Cc1cccc(Cn(c(C(NCCN2CCOCC2)=O)c2)c(cc3)c2cc3NC(COCc2ccccc2)=O)c1

InChI

InChI=1S/C32H36N4O4/c1-24-6-5-9-26(18-24)21-36-29-11-10-28(34-31(37)23-40-22-25-7-3-2-4-8-25)19-27(29)20-30(36)32(38)33-12-13-35-14-16-39-17-15-35/h2-11,18-20H,12-17,21-23H2,1H3,(H,33,38)(H,34,37)

InChI Key

UDGKVCQVZACVOR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19776978

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

540.66

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.576

Distribution Coefficient, logD

4.546

Water Solubility, LogSw

-4.52

Polar Surface Area

68.150

Acid Dissociation Constant (pKa)

12.43

Base Dissociation Constant (pKb)

6.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.30

V030-1299 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with V030-1299 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-1299?
Check Price and Availability of V030-1299, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-1299 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-1299
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-1299
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-1299 available by request